Guidelines & Advice

Modality of Care

Cancer care is delivered by many different healthcare providers using a variety of methods to address a range of patient needs. The guidelines focus on care options for specific types of cancer, and are available within the following clinical areas:

Displaying Guidelines

10 Items

An Endorsement of the 2023 International Stereotactic Radiosurgery Society’s (ISRS) Guideline: A Systematic Review Informing the Management of Symptomatic Brain Radiation Necrosis After Stereotactic Radiosurgery and ISRS Recommendations

Document Status: Current
ID: Guideline Endorsement C50-CIDAP-3

Updated

Mar 2025

Effective Teaching Strategies and Methods for Cancer Patient Education

Document Status: Current
ID: GL 20-2
Version: 2

Updated

Apr 2025

Evidence from Primary Studies and Systematic Reviews and Recommendations from Clinical Practice Guidelines January to June 2024

Document Status: Current
ID: PET 2024-1

Updated

Mar 2025

Follow-up for Cervical Cancer

Document Status: Current
ID: 4-16
Version: 2

Updated

May 2025

Ontario Cervical Screening Program: Guidance for Vaginal Vault Testing

Document Status: Current

Updated

Mar 2025

Ontario Cervical Screening Program: Interim guidance to support the transition years following the launch of human papillomavirus testing in Ontario: Cervical screening and colposcopy recommendations for people ages 21 to 24

Document Status: Current

Updated

Mar 2025

Postmastectomy Breast Reconstruction in Patients with Non-Metastatic Breast Cancer

Document Status: Current
ID: GL 17-10 v2
Version: 2

Updated

Mar 2025

Role of Adjuvant Treatment in Resected Pancreatic Ductal Adenocarcinoma

Document Status: Current
ID: GL 2-33
Version: 2

Updated

Jun 2025

T-Cell Engaging Antibodies: Management of Cytokine Release Syndrome (CRS) and Immune Effector-Associated Neurotoxicity Syndrome (ICANS)

Document Status: Current

Updated

Mar 2025

The Use of Molecular Tools for Identifying and Guiding Treatment of Cancers of Unknown Primary

Document Status: Current
ID: MOTAC-7

Updated

Jan 2025